Rhinology Practice Questions

Q: Rhinitis medicamentosa is caused by:

Nasal decongestants. **Explanation:** **Rhinitis Medicamentosa (RM)** is a condition of rebound nasal congestion caused by the prolonged use of **topical nasal decongestants** (typically >5–7 days). **Why Nasal Decongestants are the cause:** Topical decongestants (e.g., Oxymetazoline, Xylometazoline) are sympathomimetic amines that act on alpha-receptors to cause vasoconstriction. Prolonged use leads to a "rebound" phenomenon via two mechanisms: 1. **Downregulation of alpha-receptors:** The receptors become less sensitive to endogenous norepinephrine. 2. **Interstitial Edema:** Chronic vasoconstriction causes local hypoxia, leading to compensatory vasodilation and mucosal edema, which the patient then tries to treat with more spray, creating a vicious cycle. **Analysis of Incorrect Options:** * **B. Antihistaminic drugs:** These are used to *treat* allergic rhinitis. While they can cause systemic side effects like sedation or dryness, they do not cause rebound mucosal hypertrophy. * **C. Steroids:** Topical nasal steroids (e.g., Fluticasone) are actually the **treatment of choice** for Rhinitis Medicamentosa as they reduce mucosal inflammation and help wean patients off decongestants. * **D. Salbutamol:** This is a Beta-2 agonist used primarily in asthma. It does not have a significant effect on nasal mucosal vasculature to cause rhinitis. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Patients present with "red, swollen, and boggy" nasal mucosa and a history of "addiction" to nasal sprays. * **Management:** Immediate cessation of the offending spray and initiation of topical (or occasionally systemic) corticosteroids. * **Other Drugs causing Rhinitis:** Systemic drugs like antihypertensives (Reserpine, Guanethidine, Beta-blockers), oral contraceptives, and NSAIDs (Aspirin) can also cause non-allergic rhinitis, but the term "Medicamentosa" specifically refers to the rebound effect of topical sprays.

Q: A patient presents with an antrochoanal polyp arising from the medial wall of the maxilla. Which of the following would be the best management for the patient?

FESS with polypectomy. **Explanation:** **1. Why FESS with Polypectomy is the Correct Choice:** Functional Endoscopic Sinus Surgery (FESS) is currently the **gold standard** for treating antrochoanal polyps (ACP). An ACP typically originates from the maxillary sinus (most commonly the medial wall or posterior wall) and extends through the accessory ostium into the choana. FESS allows for the precise identification of the polyp’s pedicle, wide clearance of the maxillary ostium (middle meatal antrostomy), and complete removal of the cystic intramaxillary component. This approach minimizes recurrence while preserving the sinus physiology and avoiding external scars. **2. Analysis of Incorrect Options:** * **Medial Maxillectomy (TEMM):** This is an overly aggressive procedure reserved for benign or malignant tumors (e.g., Inverted Papilloma). It is not indicated for a simple inflammatory polyp. * **Caldwell-Luc Procedure:** Historically used to ensure complete removal of the antral base, it is now largely obsolete for ACPs due to risks of infraorbital nerve injury, cheek swelling, and dental damage. It is only considered in rare, recurrent cases where the pedicle is inaccessible via FESS. * **Intranasal Polypectomy:** This involves simple snare removal of the nasal part of the polyp. It almost always leads to **recurrence** because the intramaxillary "root" or stalk is left behind. **3. Clinical Pearls for NEET-PG:** * **Origin:** ACPs most commonly arise from the **medial wall** or the floor of the maxillary sinus. * **Radiology:** On CT, they show a "dumbbell-shaped" mass extending from the antrum to the choana. * **Killian’s Polyp:** Another name for the Antrochoanal Polyp. * **Key Distinction:** Unlike ethmoidal polyps (which are bilateral and multiple), ACPs are typically **unilateral and solitary**.

Q: Which of the following best differentiates an antrochoanal polyp from an ethmoidal polyp?

Best seen on posterior rhinoscopy. **Explanation:** The primary distinction between an antrochoanal (AC) polyp and ethmoidal polyps lies in their origin, direction of growth, and clinical presentation. **Why the correct answer is right:** An **Antrochoanal polyp** originates from the maxillary sinus mucosa, exits through the natural or accessory ostium, and grows backward toward the choana and nasopharynx. Because of this posterior trajectory, it is often **best seen on posterior rhinoscopy** as a smooth, grayish-white mass hanging in the choana. In contrast, ethmoidal polyps are typically confined to the nasal cavity and are easily visualized on anterior rhinoscopy. **Analysis of incorrect options:** * **A & D (Multiple and Bilateral):** These are characteristic features of **Ethmoidal polyps**, which are usually multiple, bilateral, and resemble a "bunch of grapes." AC polyps are almost always **solitary and unilateral**. * **C (Recurrence on polypectomy):** While both can recur, ethmoidal polyps have a significantly higher recurrence rate due to their association with underlying conditions like allergy or aspirin sensitivity. Simple polypectomy for an AC polyp also carries a risk of recurrence if the antral base is not addressed, making this a poor differentiating factor. **High-Yield Clinical Pearls for NEET-PG:** * **Origin:** AC polyps arise from the **maxillary sinus** (Antrum); Ethmoidal polyps arise from **ethmoidal air cells**. * **Age:** AC polyps are more common in **children/young adults**; Ethmoidal polyps are more common in **adults**. * **Radiology:** On CT, AC polyps show the **"dumbbell" shape** (constriction at the ostium). * **Treatment of Choice:** For AC polyp, it is **Functional Endoscopic Sinus Surgery (FESS)** to remove the polyp along with its antral attachment. In older patients, Caldwell-Luc surgery was historically used.

Q: Which of the following is the most common site of traumatic CSF rhinorrhea?

Ethmoid sinus. **Explanation:** The correct answer is **Ethmoid sinus (specifically the Cribriform plate/Fovea ethmoidalis)**. **Why Ethmoid Sinus is correct:** The roof of the ethmoid labyrinth (fovea ethmoidalis) and the cribriform plate represent the thinnest portions of the skull base. The bone here is extremely fragile, often measuring only 0.2 mm to 0.5 mm in thickness. Additionally, the dura mater in this region is tightly adherent to the bone. Consequently, even minor head trauma or decelerating injuries can easily fracture this area, tearing the underlying dura and leading to a Cerebrospinal Fluid (CSF) leak. **Why the other options are incorrect:** * **Frontal sinus:** While frontal bone fractures are common in high-velocity trauma, the posterior table of the frontal sinus is thicker than the ethmoid roof, making it a less frequent site for isolated leaks. * **Middle cranial fossa:** Fractures here typically involve the temporal bone. While they can cause CSF otorrhea (or rhinorrhea via the Eustachian tube), they are statistically less common than ethmoid-related leaks in blunt head trauma. * **Sphenoid sinus:** This is a rare site for traumatic leaks, usually associated with severe basilar skull fractures or iatrogenic injury during transsphenoidal surgery. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of CSF Rhinorrhea:** Traumatic (Accidental > Iatrogenic). * **Most common site of Iatrogenic leak:** Fovea ethmoidalis (during FESS). * **Confirmatory Test:** Beta-2 Transferrin (Most specific) or Beta-trace protein. * **Target/Halo Sign:** Seen when CSF is mixed with blood on a paper/linen. * **Imaging of choice:** High-Resolution CT (HRCT) of the paranasal sinuses (to locate the bony defect). * **Management:** Most traumatic leaks (80%) settle with conservative management (bed rest, head elevation, avoiding straining). If persistent, endonasal endoscopic repair is the gold standard.

Q: A 45-year-old patient presents with conductive hearing loss, facial pain in the temporoparietal and lower jaw areas, and an immobile soft palate on the right side. What is the probable diagnosis?

Trotter's syndrome. ### Explanation **Trotter’s Syndrome** (also known as the Sinus of Morgagni Syndrome) is a clinical triad (or tetrad) resulting from the lateral extension of a **Nasopharyngeal Carcinoma (NPC)**. The clinical features in this patient are explained by the local infiltration of the tumor: 1. **Conductive Hearing Loss:** Due to the infiltration of the Eustachian tube orifice, leading to Eustachian tube dysfunction and subsequent serous otitis media (glue ear). 2. **Facial Pain (Temporoparietal/Lower Jaw):** Caused by the involvement of the **Mandibular nerve (V3)** as it exits the Foramen Ovale. 3. **Immobile Soft Palate:** Due to the infiltration of the **Levator Veli Palatini** muscle (ipsilateral palatal palsy). 4. *Note: Trismus (due to pterygoid muscle involvement) is often considered the fourth component.* --- ### Analysis of Incorrect Options: * **A. Sluder’s Neuralgia:** Also known as Sphenopalatine ganglion neuralgia. It presents with lower facial pain and autonomic symptoms (rhinorrhea, lacrimation) but does not cause hearing loss or palatal palsy. * **B. Costen’s Syndrome:** This refers to Temporomandibular Joint (TMJ) dysfunction. While it causes facial pain and ear fullness, it lacks the neurological deficit of an immobile soft palate. * **C. Wallenberg’s Syndrome:** (Lateral Medullary Syndrome) A neurological condition caused by PICA occlusion. It presents with dysphagia, ataxia, and sensory loss, but not conductive hearing loss or V3 distribution pain. --- ### High-Yield Clinical Pearls for NEET-PG: * **Most common site of NPC:** Fossa of Rosenmüller. * **Etiology:** Strongly associated with **Epstein-Barr Virus (EBV)**. * **Earliest Symptom:** Often unilateral serous otitis media in an adult (always rule out NPC in such cases). * **Most common presenting sign:** Level II (Upper deep cervical) lymphadenopathy. * **Treatment of Choice:** Radiotherapy (NPC is highly radiosensitive).

Q: Which of the following statements is true regarding rhinosporidiosis?

Surgery is the primary treatment.. **Explanation:** **Rhinosporidiosis** is a chronic granulomatous infection caused by *Rhinosporidium seeberi*. Although historically classified as a fungus, it is now recognized as an aquatic protistan parasite (Mesomycetozoea). **1. Why Option C is correct:** The primary treatment for rhinosporidiosis is **wide surgical excision** (usually via endonasal or external approach) with **electrocautery of the base**. Cauterization is crucial to prevent recurrence, which is common due to the spillage of endospores during surgery. Medical therapy is generally ineffective, though **Dapsone** is sometimes used as an adjunct to inhibit the maturation of sporangia and reduce recurrence rates. **2. Why other options are incorrect:** * **Option A:** While it presents as a granuloma, *R. seeberi* is **not a fungus**. It is a taxonomically unique eukaryotic pathogen. * **Option B:** Clinically, it presents as a **leafy, polypoidal, strawberry-like mass** that is highly vascular and bleeds easily on touch. It is typically **pinkish-red**, not grayish (grayish masses are more characteristic of ethmoidal polyps). * **Option D:** Radiotherapy has no role in the management of this infectious condition; it is reserved for malignancies. **High-Yield Clinical Pearls for NEET-PG:** * **Epidemiology:** Most common in South India (Tamil Nadu, Kerala) and Sri Lanka; associated with bathing in stagnant pond water. * **Histopathology:** Characterized by numerous **sporangia** in various stages of development, containing thousands of **endospores**. These stain well with GMS, PAS, and Mucicarmine. * **Site:** The **nasal septum** and floor of the nose are the most common sites, but it can affect the conjunctiva (Ocular rhinosporidiosis).

Q: What is the best treatment for Stage 2B nasopharyngeal angiofibroma?

Surgery. **Explanation:** Juvenile Nasopharyngeal Angiofibroma (JNA) is a benign but locally aggressive, highly vascular tumor typically seen in adolescent males. According to the **Radkowski or Fisch classification**, Stage 2B refers to a tumor that has extended into the pterygopalatine fossa or involves the maxillary sinus with significant bone destruction. **1. Why Surgery is the Correct Answer:** Surgery remains the **gold standard and definitive treatment** for JNA across most stages (Stage I to III). For Stage 2B, the surgical approach (often endoscopic or open via Maxillary Swing/Transpalatal) is preceded by **pre-operative embolization** (usually 24–48 hours prior) to minimize intraoperative hemorrhage. Complete surgical excision offers the highest cure rate and prevents local recurrence. **2. Why Other Options are Incorrect:** * **Radiotherapy:** This is generally reserved for **Stage IV (advanced intracranial extension)**, unresectable tumors, or recurrent cases where surgery poses a high risk to vital structures. It is not the first-line treatment for Stage 2B due to the risk of secondary malignancies and growth retardation in young patients. * **Chemotherapy:** JNA is not a chemosensitive tumor. Hormonal therapy (e.g., Flutamide) has been studied but is not a standard primary treatment. **Clinical Pearls for NEET-PG:** * **Origin:** Sphenopalatine foramen (near the posterior end of the middle turbinate). * **Classic Sign:** **Holman-Miller Sign** (Antral Sign) – anterior bowing of the posterior wall of the maxillary sinus on CT/MRI. * **Diagnosis:** Clinical and radiological. **Biopsy is contraindicated** due to the extreme risk of profuse bleeding. * **Blood Supply:** Most commonly the **Internal Maxillary Artery** (branch of the External Carotid).

Q: What is characteristic of an antrochoanal polyp?

It is single and grows posteriorly.. **Explanation:** An **Antrochoanal Polyp (Killian’s Polyp)** is a solitary, non-neoplastic growth that originates from the mucosa of the maxillary antrum. It exits through the accessory ostium (or natural ostium) into the nasal cavity and extends **posteriorly** toward the choana and nasopharynx. * **Why Option A is correct:** Unlike ethmoidal polyps, antrochoanal polyps are typically **unilateral and solitary**. Their growth pattern is dictated by the inspiratory airflow and ciliary action, which directs them backward (posteriorly) into the choana. They consist of three parts: antral, nasal, and choanal. * **Why Option B is incorrect:** Multiple polyps are characteristic of **Ethmoidal polyps**, which are usually bilateral, grape-like clusters associated with allergies or chronic sinusitis. * **Why Option C is incorrect:** Polyps are generally avascular and insensitive to touch. **Bleeding (epistaxis)** is a red flag for malignancy or an Angiofibroma, not a simple antrochoanal polyp. **High-Yield Clinical Pearls for NEET-PG:** * **Origin:** Most commonly from the **maxillary sinus** (specifically the posterior wall/floor). * **Age Group:** More common in children and young adults. * **Presentation:** Unilateral nasal obstruction (often more pronounced during expiration due to the "ball-valve" effect). * **Radiology:** On X-ray (Water’s view), it shows opacity of the involved maxillary sinus. On CT, it shows a dumbbell-shaped mass extending from the sinus to the nasopharynx. * **Treatment of Choice:** Functional Endoscopic Sinus Surgery (**FESS**) to remove the polyp and its base to prevent recurrence. (Historical treatment was Caldwell-Luc surgery).

Question 1

Rhinitis medicamentosa is caused by:

Accepted Answer

Nasal decongestants

Answer

Antihistaminic drugs

Answer

Steroids

Answer

Salbutamol

Question 2

A patient presents with an antrochoanal polyp arising from the medial wall of the maxilla. Which of the following would be the best management for the patient?

Accepted Answer

FESS with polypectomy

Answer

Medial maxillectomy (TEMM)

Answer

Caldwell-Luc procedure

Answer

Intranasal polypectomy

Question 3

Which of the following best differentiates an antrochoanal polyp from an ethmoidal polyp?

Accepted Answer

Best seen on posterior rhinoscopy

Answer

Multiple

Answer

Recurrence on polypectomy

Answer

Bilateral

Question 4

Presence of which of the following is confirmatory for CSF rhinorrhea?

Accepted Answer

beta-2 transferrin

Answer

Glucose

Answer

beta-trace protein

Answer

alpha-fetoprotein

Question 5

Which of the following is the most common site of traumatic CSF rhinorrhea?

Accepted Answer

Ethmoid sinus

Answer

Frontal sinus

Answer

Middle cranial fossa

Answer

Sphenoid sinus

Question 6

A 45-year-old patient presents with conductive hearing loss, facial pain in the temporoparietal and lower jaw areas, and an immobile soft palate on the right side. What is the probable diagnosis?

Accepted Answer

Trotter's syndrome

Answer

Sluder's neuralgia

Answer

Costen's syndrome

Answer

Wallenberg's syndrome

Question 7

A 35-year-old man with a Lefort III fracture complains of blood-tinged watery discharge from his nose 2 days after the trauma. CT scan confirms NOE fracture as well. What is the most common complication of CSF rhinorrhea?

Accepted Answer

Ascending Meningitis

Answer

Brain herniation

Answer

Blindness

Answer

Cavernous sinus thrombosis

Question 8

Which of the following statements is true regarding rhinosporidiosis?

Accepted Answer

Surgery is the primary treatment.

Answer

It presents as a fungal granuloma.

Answer

It appears as a grayish mass.

Answer

Radiotherapy is the recommended treatment.

Question 9

What is the best treatment for Stage 2B nasopharyngeal angiofibroma?

Accepted Answer

Surgery

Answer

Chemotherapy

Answer

Radiotherapy

Answer

None of the above

Question 10

What is characteristic of an antrochoanal polyp?

Accepted Answer

It is single and grows posteriorly.

Answer

It is multiple.

Answer

It is characterized by bleeding.

Answer

None of the above.

Rhinology — MCQs

Rhinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?